• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与肾上腺静脉采血相比,镓-五肽胃泌素PET/CT是原发性醛固酮增多症亚型分型的一种补充方法。

Ga-pentixafor PET/CT Is a Supplementary Method for Primary Aldosteronism Subtyping Compared with Adrenal Vein Sampling.

作者信息

Yi Tieci, Lu Difei, Cui Yonggang, Zhang Zheng, Yang Xing, Zhang Jianhua, Qiu Lin, Weng Haoyu, Liu Lin, Duan Xiaojiang, Zhao Guangyu, Ma Wei, Gao Ying, Fan Yan

机构信息

Department of Cardiology, Peking University First Hospital, Beijing, China.

Institute of Cardiovascular Disease, Peking University First Hospital, Beijing, China.

出版信息

Mol Imaging Biol. 2025 Feb;27(1):142-150. doi: 10.1007/s11307-024-01976-0. Epub 2024 Dec 23.

DOI:10.1007/s11307-024-01976-0
PMID:39715984
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11805762/
Abstract

PURPOSE

To investigate the diagnostic efficacy of Ga-pentixafor positron emission tomography/computed tomography (PET/CT) in primary aldosteronism (PA) subtyping and lateralization of aldosterone secretion in PA patients.

PROCEDURES

37 patients who were diagnosed with PA, were prospectively enrolled in the study, and underwent adrenal vein sampling (AVS) after Ga-pentixafor PET/CT was conducted. Lateralization index (LI), defined as aldosterone/cortisol ratio in the dominant side to the contralateral adrenal vein when bilateral adrenal vein catheterization succeeded, and the aldosterone/cortisol ratio in the left adrenal vein to IVC (LAV/IVC) when the catheterization of right adrenal vein failed, were applied to determine lateralization side. Statistical analysis was performed using SPSS 21.0.

RESULTS

The female proportion of all patients with PA was 32.4% (12/37), and the mean age was 51.3 ± 10.9 years. Patients with bilateral adrenal mass accounted for 54.1% (20/37), and 10 of them (27.0%) had adrenal hyperplasia or adrenal nodules ≤ 1.0 cm. In all 37 patients, the sensitivity, specificity and accuracy of Ga-pentixafor PET/CT in distinguishing lateralization by visualization were 89.3%, 77.8% and 86.5%, respectively. The area under the ROC curve for detecting positive lateralization based on the value of Ga-pentixafor SUV was 0.750 (95%CI 0.578-0.922, p = 0.026). The optimum SUV cut-off value was 6.86, with the sensitivity of 78.6%, specificity of 66.7%, and accuracy of 78.4%. Defining SUV ratio as SUV/SUV of contralateral adrenal gland, the area under the ROC curve for identifying lateralization based on the SUV ratio was 0.710 (95%CI 0.500-0.921, p = 0.061). The optimum SUV ratio cut-off was 2.40, with the sensitivity of 60.7%, specificity of 88.9%, and accuracy of 67.6%. The consistency of Ga-pentixafor PET/CT with AVS was of no significant difference between patients with bilateral adrenal lesions (80.0%, 16/20) and unilateral lesion (94.1%, 16/17; p = 0.737), and no significance was revealed in the consistency between patients with adrenal hyperplasia or adrenal lesion of diameter ≤ 1 cm (81.8%, 9/11) and those with adrenal lesions > 1 cm (88.5%, 23/26; p = 0.884).

CONCLUSIONS

Ga-pentixafor PET/CT showed at least 80% consistency for the lateralization in patients with PA compared with AVS, even in those presented with bilateral adrenal hyperplasia. Visual analysis exhibited better diagnostic efficacy compared with SUV or SUV/SUV of the contralateral adrenal gland.( ChiCTR2300073049. Registered 30 June 2023. Retrospectively registered).

摘要

目的

探讨镓喷替酸正电子发射断层扫描/计算机断层扫描(PET/CT)在原发性醛固酮增多症(PA)亚型诊断及PA患者醛固酮分泌侧别定位中的诊断效能。

方法

37例确诊为PA的患者前瞻性纳入本研究,在进行镓喷替酸PET/CT后接受肾上腺静脉采血(AVS)。侧别指数(LI)定义为双侧肾上腺静脉插管成功时优势侧肾上腺静脉与对侧肾上腺静脉的醛固酮/皮质醇比值,以及右侧肾上腺静脉插管失败时左肾上腺静脉与下腔静脉的醛固酮/皮质醇比值(LAV/IVC),用于确定侧别。使用SPSS 21.0进行统计分析。

结果

所有PA患者中女性占32.4%(12/37),平均年龄为51.3±10.9岁。双侧肾上腺肿块患者占54.1%(20/37),其中10例(27.0%)有肾上腺增生或肾上腺结节≤1.0 cm。在所有37例患者中,镓喷替酸PET/CT通过可视化鉴别侧别的敏感性、特异性和准确性分别为89.3%、77.8%和86.5%。基于镓喷替酸SUV值检测阳性侧别的ROC曲线下面积为0.750(95%CI 0.578 - 0.922,p = 0.026)。最佳SUV截断值为6.86,敏感性为78.6%,特异性为66.7%,准确性为78.4%。将SUV比值定义为SUV/对侧肾上腺SUV,基于SUV比值识别侧别的ROC曲线下面积为0.710(95%CI 0.500 - 0.921,p = 0.061)。最佳SUV比值截断值为2.40,敏感性为60.7%,特异性为88.9%,准确性为67.6%。镓喷替酸PET/CT与AVS的一致性在双侧肾上腺病变患者(80.0%,16/20)和单侧病变患者(94.1%,16/17;p = 0.737)之间无显著差异,肾上腺增生或直径≤1 cm肾上腺病变患者(81.8%,9/11)与肾上腺病变>1 cm患者(88.5%,23/26;p = 0.884)之间的一致性也无显著差异。

结论

与AVS相比,镓喷替酸PET/CT在PA患者侧别定位中显示出至少80%的一致性,即使在双侧肾上腺增生患者中也是如此。视觉分析显示出比SUV或对侧肾上腺SUV/SUV更好的诊断效能。(ChiCTR2300073049。2023年6月30日注册。回顾性注册)

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5b8/11805762/ff32155ad36a/11307_2024_1976_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5b8/11805762/ff32155ad36a/11307_2024_1976_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5b8/11805762/ff32155ad36a/11307_2024_1976_Fig1_HTML.jpg

相似文献

1
Ga-pentixafor PET/CT Is a Supplementary Method for Primary Aldosteronism Subtyping Compared with Adrenal Vein Sampling.与肾上腺静脉采血相比,镓-五肽胃泌素PET/CT是原发性醛固酮增多症亚型分型的一种补充方法。
Mol Imaging Biol. 2025 Feb;27(1):142-150. doi: 10.1007/s11307-024-01976-0. Epub 2024 Dec 23.
2
Typing diagnostic value of Ga-pentixafor PET/CT for patients with primary aldosteronism and unilateral nodules.Ga-五氮杂环十二烷四乙酸正电子发射断层显像/X线计算机体层成像对原发性醛固酮增多症伴单侧结节患者的分型诊断价值
Endocrine. 2025 Jan;87(1):314-324. doi: 10.1007/s12020-024-04024-7. Epub 2024 Sep 9.
3
Accuracy of Gallium-68 Pentixafor Positron Emission Tomography-Computed Tomography for Subtyping Diagnosis of Primary Aldosteronism.镓-68 吡咯烷酮[¹¹C]戊烷多靶素正电子发射断层扫描-计算机断层扫描用于原发性醛固酮增多症的亚型诊断的准确性。
JAMA Netw Open. 2023 Feb 1;6(2):e2255609. doi: 10.1001/jamanetworkopen.2022.55609.
4
Clinical Value of Ga-Pentixafor PET/CT in Subtype Diagnosis of Primary Aldosteronism Patients with Adrenal Micronodules.Ga- 培哚普利他胺 PET/CT 在肾上腺微结节原发性醛固酮增多症患者亚型诊断中的临床价值。
J Nucl Med. 2024 Jan 2;65(1):117-124. doi: 10.2967/jnumed.123.266061.
5
Clinical Utility of Dual-Time Ga-Pentixafor PET/CT in Diagnosing and Subtyping Primary Aldosteronism.双时相镓-喷替沙氟PET/CT在原发性醛固酮增多症诊断及亚型分类中的临床应用
Clin Endocrinol (Oxf). 2025 May;102(5):499-509. doi: 10.1111/cen.15204. Epub 2025 Jan 26.
6
A comparison of the performance of Ga-Pentixafor PET/CT adrenal vein sampling for subtype diagnosis in primary aldosteronism.原发性醛固酮增多症亚型诊断中 Ga-Pentixafor PET/CT 肾上腺静脉采样的性能比较。
Front Endocrinol (Lausanne). 2024 Feb 14;15:1291775. doi: 10.3389/fendo.2024.1291775. eCollection 2024.
7
CXCR4-directed [Ga]Ga-PentixaFor PET/CT versus adrenal vein sampling performance: a study protocol for a randomised two-step controlled diagnoStic Trial Ultimately comparing hypertenSion outcome in primary aldosteronism (CASTUS).基于 CXCR4 的[Ga]Ga-戊基替他索 PET/CT 与肾上腺静脉取样性能的对比:一项旨在比较原发性醛固酮增多症(CASTUS)中高血压结局的随机两步对照诊断试验研究方案
BMJ Open. 2022 Aug 23;12(8):e060779. doi: 10.1136/bmjopen-2022-060779.
8
Ga-pentixafor PET/CT in the localization diagnosis of primary aldosteronism concurrent subclinical cushing's syndrsome: two case reports.Ga-苯并戊烯托 PET/CT 在原发性醛固酮增多症并发亚临床库欣综合征定位诊断中的应用:两例报告。
Endocrine. 2024 Sep;85(3):1398-1406. doi: 10.1007/s12020-024-03865-6. Epub 2024 Jun 24.
9
Functional nodules in primary aldosteronism: identification of CXCR4 expression with Ga-pentixafor PET/CT.原发性醛固酮增多症中的功能性结节:用 Ga-前列腺素 F PET/CT 识别 CXCR4 的表达。
Eur Radiol. 2023 Feb;33(2):996-1003. doi: 10.1007/s00330-022-09058-x. Epub 2022 Sep 7.
10
Functional Characterization of Adrenocortical Masses in Nononcologic Patients Using Ga-Pentixafor.使用镓-喷替沙氟对非肿瘤患者肾上腺皮质肿块进行功能表征
J Nucl Med. 2022 Mar;63(3):368-375. doi: 10.2967/jnumed.121.261964. Epub 2021 Jul 22.

引用本文的文献

1
Is CXCR4-targeted Ga-pentixafor PET/CT a reliable AVS-free modality for surgical decision-making and prognostic prediction in primary aldosteronism with bilateral adrenal lesions?靶向CXCR4的镓-喷替沙氟PET/CT对于双侧肾上腺病变的原发性醛固酮增多症的手术决策和预后预测而言,是否是一种可靠的无需肾上腺静脉采样的方法?
EJNMMI Res. 2025 Aug 28;15(1):111. doi: 10.1186/s13550-025-01309-4.

本文引用的文献

1
A comparison of the performance of Ga-Pentixafor PET/CT adrenal vein sampling for subtype diagnosis in primary aldosteronism.原发性醛固酮增多症亚型诊断中 Ga-Pentixafor PET/CT 肾上腺静脉采样的性能比较。
Front Endocrinol (Lausanne). 2024 Feb 14;15:1291775. doi: 10.3389/fendo.2024.1291775. eCollection 2024.
2
Predicting Bilateral Subtypes of Primary Aldosteronism Without Adrenal Vein Sampling: A Systematic Review and Meta-analysis.无需肾上腺静脉取样预测原发性醛固酮增多症的双侧亚型:系统评价和荟萃分析。
J Clin Endocrinol Metab. 2024 Jan 18;109(2):e837-e855. doi: 10.1210/clinem/dgad451.
3
The Value of Targeting CXCR4 With 68Ga-Pentixafor PET/CT for Subtyping Primary Aldosteronism.
用 68Ga-培哚普利酸 PET/CT 靶向 CXCR4 对原发性醛固酮增多症进行亚型分类的价值。
J Clin Endocrinol Metab. 2023 Dec 21;109(1):171-182. doi: 10.1210/clinem/dgad421.
4
Functional nodules in primary aldosteronism: identification of CXCR4 expression with Ga-pentixafor PET/CT.原发性醛固酮增多症中的功能性结节:用 Ga-前列腺素 F PET/CT 识别 CXCR4 的表达。
Eur Radiol. 2023 Feb;33(2):996-1003. doi: 10.1007/s00330-022-09058-x. Epub 2022 Sep 7.
5
Primary aldosteronism - a multidimensional syndrome.原发性醛固酮增多症——一种多维综合征。
Nat Rev Endocrinol. 2022 Nov;18(11):665-682. doi: 10.1038/s41574-022-00730-2. Epub 2022 Aug 31.
6
Adrenal vein sampling: technique and protocol, a systematic review.肾上腺静脉采血:技术与方案,一项系统评价
CVIR Endovasc. 2021 Apr 1;4(1):38. doi: 10.1186/s42155-021-00220-y.
7
Imaging CXCR4 expression in patients with suspected primary hyperaldosteronism.疑似原发性醛固酮增多症患者CXCR4表达的影像学研究
Eur J Nucl Med Mol Imaging. 2020 Oct;47(11):2656-2665. doi: 10.1007/s00259-020-04722-0. Epub 2020 Mar 23.
8
Development and validation of subtype prediction scores for the workup of primary aldosteronism.原发性醛固酮增多症筛查的亚型预测评分的制定与验证。
J Hypertens. 2018 Nov;36(11):2269-2276. doi: 10.1097/HJH.0000000000001855.
9
Targeting CXCR4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing Adenoma.靶向 CXCR4(CXC 趋化因子受体型 4)用于醛固酮分泌腺瘤的分子成像。
Hypertension. 2018 Feb;71(2):317-325. doi: 10.1161/HYPERTENSIONAHA.117.09975. Epub 2017 Dec 26.
10
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort.单侧原发性醛固酮增多症肾上腺切除术的结局:国际共识的结局指标和国际队列缓解率分析。
Lancet Diabetes Endocrinol. 2017 Sep;5(9):689-699. doi: 10.1016/S2213-8587(17)30135-3. Epub 2017 May 30.